Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.

REC | XMIL

Overview

Corporate Details

ISIN(s):
IT0003828271 (+4 more)
LEI:
815600FBF92FD3531704
Country:
Italy
Address:
VIA MATTEO CIVITALI, 1, 20148 MILANO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Recordati Industria Chimica e Farmaceutica is an international pharmaceutical group dedicated to the research, development, manufacturing, and marketing of pharmaceuticals. With a history of nearly 100 years, the company develops and commercializes drugs for both common pathologies and rare diseases, operating in approximately 150 countries. Its business model integrates a chemicals division that produces and supplies Active Pharmaceutical Ingredients (APIs) to a global customer base alongside its core pharmaceutical operations. The group focuses on improving the health and quality of life for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 20:07
Regulatory News Service
RECORDATI: Update on the execution of the share buy-back program
Italian 734.0 KB
2025-10-08 20:05
Regulatory News Service
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 231.5 KB
2025-10-07 20:07
Regulatory News Service
Allegato 3F
Italian 30.0 KB
2025-10-01 20:08
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 770.3 KB
2025-10-01 20:07
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 1016.9 KB
2025-09-23 20:05
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 611.2 KB
2025-09-23 20:04
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 907.3 KB
2025-09-18 20:04
Board/Management Information
RECORDATI ANNOUNCES RESIGNATION OF LUIGI LA CORTE AS GROUP CFO WHILE MAINTAININ…
English 172.7 KB
2025-09-18 20:02
Board/Management Information
RECORDATI COMUNICA LE DIMISSIONI DI LUIGI LA CORTE DAL RUOLO DI GROUP CFO, MANT…
Italian 158.3 KB
2025-09-17 20:07
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 813.4 KB
2025-09-17 20:04
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 771.3 KB
2025-09-10 20:09
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 334.7 KB
2025-09-10 20:06
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 291.7 KB
2025-09-03 20:15
Director's Dealing
Allegato 3F
Italian 29.8 KB
2025-09-03 20:06
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 796.0 KB

Automate Your Workflow. Get a real-time feed of all Recordati Industria Chimica e Farmaceutica filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Recordati Industria Chimica e Farmaceutica via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.